Vertex will make $21bn from cystic fibrosis drug
The US company, Vertex, is claiming that it must price its cystic fibrosis drug, Orkambi, at a high level to … Read more
Vertex
The US company, Vertex, is claiming that it must price its cystic fibrosis drug, Orkambi, at a high level to … Read more